Northwestern University Feinberg School of Medicine, 675 North St. Clair, Suite 14-100, Chicago, IL, 60611, USA.
Arthritis Res Ther. 2017 Dec 22;19(1):286. doi: 10.1186/s13075-017-1493-8.
Current classification criteria for axial spondyloarthritis (axSpA) provide for the inclusion of patients with a wide range of presentations and manifestations. While not considered a formal subclassification, patients are often divided into radiographic or nonradiographic axSpA based on the presence or absence of radiographic sacroiliitis. This review will focus on nonradiographic axSpA and will discuss clinical manifestations of disease that distinguish, or in many cases do not distinguish, this entity from other individuals with axSpA. This review will also cover treatment paradigms for nonradiographic axSpA, particularly the use of biologic therapies, where current data suggest that nonradiographic disease should be managed largely the same as radiographic disease, or classical ankylosing spondylitis.
目前,轴性脊柱关节炎(axSpA)的分类标准纳入了具有广泛表现和特征的患者。虽然影像学骶髂关节炎的有无不作为正式的亚分类,但常基于此将患者分为放射学或非放射学 axSpA。本综述将重点关注非放射学 axSpA,并讨论可区分或在许多情况下无法区分该疾病与其他 axSpA 患者的疾病临床表现。本综述还将涵盖非放射学 axSpA 的治疗模式,特别是生物治疗的应用,目前的数据表明,非放射学疾病的管理应与放射学疾病或经典强直性脊柱炎基本相同。